These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 36253712)

  • 1. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
    Nathania I; Nainggolan IM; Yasmon A; Nusatia ACM; Tjoa E; Gunardi WD; Moehario LH
    BMC Microbiol; 2022 Oct; 22(1):250. PubMed ID: 36253712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
    Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
    Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure.
    Dahiya S; Kapil A; Lodha R; Kumar R; Das BK; Sood S; Kabra SK
    Indian J Med Res; 2014 May; 139(5):746-53. PubMed ID: 25027085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
    Ling JM; Chan EW; Lam AW; Cheng AF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics in adult patients with Salmonella bacteremia and analysis of ciprofloxacin-nonsusceptible isolates.
    Cheng MW; Lee CM; Wang NY; Wu AY; Lin CC; Weng LC; Liu CP; Shih SC
    J Microbiol Immunol Infect; 2015 Dec; 48(6):692-8. PubMed ID: 26542649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
    Pérez-Vázquez M; Román F; Aracil B; Cantón R; Campos J
    J Clin Microbiol; 2004 Mar; 42(3):1185-91. PubMed ID: 15004073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
    Eaves DJ; Randall L; Gray DT; Buckley A; Woodward MJ; White AP; Piddock LJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.
    García-Fernández A; Gallina S; Owczarek S; Dionisi AM; Benedetti I; Decastelli L; Luzzi I
    PLoS One; 2015; 10(6):e0132065. PubMed ID: 26121266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.
    Hirose K; Hashimoto A; Tamura K; Kawamura Y; Ezaki T; Sagara H; Watanabe H
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3249-52. PubMed ID: 12234852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana.
    Acheampong G; Owusu M; Owusu-Ofori A; Osei I; Sarpong N; Sylverken A; Kung HJ; Cho ST; Kuo CH; Park SE; Marks F; Adu-Sarkodie Y; Owusu-Dabo E
    BMC Infect Dis; 2019 Oct; 19(1):898. PubMed ID: 31660876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
    Chau TT; Campbell JI; Galindo CM; Van Minh Hoang N; Diep TS; Nga TT; Van Vinh Chau N; Tuan PQ; Page AL; Ochiai RL; Schultsz C; Wain J; Bhutta ZA; Parry CM; Bhattacharya SK; Dutta S; Agtini M; Dong B; Honghui Y; Anh DD; Canh DG; Naheed A; Albert MJ; Phetsouvanh R; Newton PN; Basnyat B; Arjyal A; La TT; Rang NN; Phuong LT; Van Be Bay P; von Seidlein L; Dougan G; Clemens JD; Vinh H; Hien TT; Chinh NT; Acosta CJ; Farrar J; Dolecek C
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4315-23. PubMed ID: 17908946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China.
    Qian H; Cheng S; Liu G; Tan Z; Dong C; Bao J; Hong J; Jin D; Bao C; Gu B
    Sci Rep; 2020 Apr; 10(1):7359. PubMed ID: 32355184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
    Lee CJ; Su LH; Huang YC; Chiu CH
    J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.